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Introduction: The development in therapeutic strategies has increased survival of children affected by inborn
errors of metabolism with restricted diet (IEMRD). These diseases have mild- and long-term consequences on the
health. Little is known about the impact on the quality of life (QoL) of children and their families. The aims of this
study were: to compare the QoL of the children and parents affected by IEMRD with the QoL of the general
population and one pathology associated with long-term consequences.
Patients and methods: This cross-sectional study was performed at the French Reference Center for inborn
metabolic disorders (Marseille, France). Inclusion criteria were: a child with a diagnosis of organic aciduria, urea
cycle defect, or maple syrups urine disease (MSUD). Socio-demographics, clinical data, and QoL were recorded.
Results: Twenty-one of 32 eligible families were included during a planned routine visit. Ten (47%, 95% CI 27-69%)
children were affected by organic aciduria, six (29%, 95% CI 10-48%) by urea cycle defects, and five (24%, 95% CI
6-42%) by MSUD. Among the younger children, the general well-being was significantly lower in the children with
IEMRD than in the leukemia children (58 ± 16 versus 76 ± 15, p = 0.012), and among the older children, the leisure
activities were significantly lower in the children with IEMRD than in the leukemia children (29 ± 18 versus 62 ± 22,
p < 10-3), while the relationships with teachers were better (76 ± 23 versus 60 ± 23, p = 0.01). The physical QoL
score was lower in the parents than in the French norms (66 ± 21 versus 75 ± 1, p = 0.05). Factors modulating
QoL were: eating and neurologic disorders, enteral nutrition, and feeding modalities.
Conclusion: The children and the parents of children affected presented altered ‘physical’ and ‘social’ QoL scores
compared with the norms and patients with leukemia and their families. Future studies based on larger cohort
studies should determine the different weights of potential predictive factors of QoL.
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Inborn errors of metabolism (IEM) are a heterogeneous
group of genetic diseases that affect metabolic pathways
[1]. In this group, certain diseases require diets that in-
clude a restrictive lifelong regime when the patient has
a stable clinical status and a specific emergency regime
when the patient has an unstable clinical status. IEM
caused by a deficiency in the activity of an enzyme that
is responsible for the catabolism of amino acids or for
the urea cycle constitute a group that requires a protein-
restricted diet [2], known as IEM with restricted diet
(IEMRD). The rapid development of diagnostic and thera-
peutic possibilities has increased survival and defined
IEMRD as chronic illnesses [3].
However, the disease and its treatment have both
physical and psychological effects on children and their
families: poor growth due to the prolonged restricted
diet [4-6], motor disorders [6-8], hepatic disorders [4,9],
renal disorders [4,6,10], and neurocognitive disorders
[6,8,11,12]. Mild- and long-term consequences of the
diseases lead to an interest in assessing quality of life
(QoL) and in clinical follow-up for surviving children
[13-23].
Among the studies exploring the QoL of IEMRD pa-
tients, certain limitations should be mentioned, related
to the evaluation of heterogeneous samples in terms of
the nature of diseases, the assessment methods, and the
treatment modalities. No studies connected children’s and
parents’ QoL, and no data related to QoL determinants
were available. In this work, we explored the QoL of
children affected by three IEMRD conditions that needed
the same treatment strategy, combining a long-term
hypoproteic diet and an emergency diet in case of
metabolic decompensation (due to stress, anesthesia, or
infection): organic aciduria, a urea cycle defect, and MSUD.
The objectives of our study were i) to compare the QoL
levels of the children and parents affected by these
three IEMRD conditions with the levels observed in the
general population and in another pathology associated
with long-term consequences (childhood leukemia sur-
vivors), ii) to assess the potential factors modulating
the QoL of children and parents, and iii) to assess the
relationship between the children’s and parents’ QoL
scores.
Materials and methods
Study design and population
This study incorporated a cross-sectional design and was
performed at the Reference Center for inborn metabolic
disorders of a French public teaching hospital (La Timone,
Marseille, France).
The inclusion criteria were as follows: a child with a
diagnosis of one of three IEMRD conditions (organic
aciduria, urea cycle defect, or MSUD), born between1993 and 2010, with parents or legal guardians authorizing
participation in the study. A medical database allowed
the identification of eligible children according to the
selection criteria. The study was proposed to consecutive
parents and/or patients during a planned routine visit.
Ethic aspects
According to the French law (Article L1121-1, Law n°
2011-2012 29 december 2011 - art. 5), ethical approval
is not needed for researches in which all actions are
performed and products used routinely. This study was
conducted in accordance with the Declaration of Helsinki
and French Good Clinical Practices. Consent was collected
for each eligible family.
Medical records
From the medical records, the following data were col-
lected: 1. sociodemographic: age and gender of the child;
2. clinical: nature of IEMRD (organic aciduria, urea cycle
defect, or MSUD), feeding modalities at inclusion (exclu-
sively oral, home enteral nutrition), eating disorders at
inclusion (presence or absence), current gastrostomy, and
previous enteral nutrition; and 3. current clinical compli-
cations: neurologic (motor, sensory, or cognitive impair-
ment), renal (based on creatine clearance level), cardiac
(based on echocardiography), hepatic (biological markers),
and protein-related (based on actual protein intake rate).
Evaluation of QoL
The QoL of the children and adolescents was assessed
using the Vécu et Santé Perçue de l’Adolescent et de
l’Enfant (VSP-A) questionnaire [24-27]. Two child versions
were available: the VSP-Ae, designed to be answered by
children aged from 8 to 10 years, and the VSP-A,
designed to be answered by adolescents aged from 11
to 17 years. One parent version is available: the VSP-Ap,
designed to be answered by the parents of children or
adolescents of all ages. The 38-item child version (VSP-
Ae), described eight dimensions and an index: relations
with parents/family (RFa), body image (BI), vitality (VIT),
relations with friends (RFr), general well-being (GWB),
leisure activities (LEI), school performance (SCH), and
relations with medical staff (RMS). The 39-item adoles-
cent version (VSP-A), described 10 dimensions and an
index: relations with parents/family (RFa), body image (BI),
vitality (VIT), relations with friends (RFr), psychological
well-being (PsWB), physical well-being (PhWB), leisure
activities (LEI), school performance (SCH), relations with
teachers (RT), and relations with medical staff (RMS).
The 37-item parent version (VSP-Ap), described 10 di-
mensions and an index: relations with parents (Rpa), body
image (BI), vitality (VIT), relations with friends (RFr),
leisure activities (LEI), psychological well-being (PsWB),
physical well-being (PhWB), school performance (SCH);
Table 1 Patients characteristics
1. Children N = 21 N (%)
Sex Boys 10 (47.6)
Girls 11 (52.4)
Age (years) Mean ± SD 8.25 ± 5.60
M (min-max) 8.6 (1–18)
Nature of IEMRD Organic aciduria 10 (47.6)
Urea cycle defect 6 (28.6)
MSUD 5 (23.8)
Feeding modality at inclusion Exclusively oral 12 (57.1)
Oral and gastrostomy 9 (42.9)
Eating disorders at inclusion 6 (28.5)




Enteral nutrition 15 (71.4)
Current gastrostomy 8 (38.1)
Protein (Gr/kg/j) Mean ± SD 1.07 ± 0.32
M (min-max) 1.14 (0.18-1.49)
Natural protein (Gr/kg/j) Mean ± SD 0.67 ± 0.29
M (min-max) 0.71 (0.17-1.16)
2. Parents N = 21
Age (years) Mean ± SD 39.14 ± 6.64
M (min-max) 39 (30–58)
Occupational status Yes 11 (52.4)
No 10 (47.6)
IEMRD: Inborn errors of metabolism with restricting dietary.
MSUD: maple syrup urine disease.
SD standard deviation, M median, min-max minimum and maximum.
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staff (RMS). All scores range between 0 and 100, with
higher scores indicating a better QoL. French norms are
available [28]. The scores of childhood leukemia survivors
are also available (from the LEA cohort) [29]. These
data are the property of one of the author (PA) and
their use needs no special permission.
The QoL of the parents was assessed using the French
version of the World Health Organization Quality of Life
(WHOQOL-BREF) questionnaire, which is a generic ques-
tionnaire used worldwide [30,31] that describes four
domains: physical health, psychological health, social
relationships, and environment. French norms are avail-
able only for three domains [32].
Statistical analysis
Continuous variables were expressed as the means and
standard deviations and the medians and ranges. Quali-
tative variables were expressed as percentages. Nonpara-
metric statistics were employed. The VSP-A scores were
compared with the scores obtained from a sample of
childhood leukemia survivors [29] and from French con-
trols from a normative sample of 1060 subjects [28]. The
WHOQOL-BREF scores of the parents were compared
with the scores obtained from French controls from a
normative sample of 16000 subjects [32]. Comparisons of
mean QoL scores between different subgroups (gender
of the child, nature of the IEMRD, feeding modality,
eating disorders, other clinical disorders, previous or
current enteral nutrition, and current gastrostomy) were
performed using Mann–Whitney tests. Correlations
between children’s QoL scores and parents’ QoL scores
were tested using paired Student’s t-tests. The statistical
analyses were performed using the SPSS software package,
version 17.0 (SPSS Inc., Chicago, IL, USA). All tests were
two-sided. Statistical significance was defined as p < 0.05.
Results
Sample
Among 32 eligible families, 11 were non-respondents
due to abortive contact and refusal to participate. The
respondents and non-respondents did not differ according
to age or the nature of the IEMRD. Ten children were
affected by organic aciduria, six by urea cycle defects,
and five by MSUD. The mean age was 98.7 months
(SD: 67.1). At the time of evaluation, 12 children were fed
exclusively orally, nine received home enteral nutrition,
and eight had a gastrostomy. Disorders of any nature
(neurologic, renal, cardiac, and hepatic) were reported in
62% of the children. All of the characteristics are detailed
in Table 1. Ten children specified their QoL (six using
VSP-A and four using VSP-Ae). Fourteen parents specified
the QoL of their children using the VSP-Ap, and 21
parents specified their own QoL using the WHOQOL.QoL of IEMRD sample compared with general population
and leukemia
QoL of children and adolescents
- QoL of children from self-report The QoL scores of
the children aged from 8 to 10 years are shown in Figure 1.
The relations with friends was the dimension with the
most altered score, and the vitality dimension score
was the least altered. The scores of the children with
IEMRD were always lower than the scores of the long-
term survivors of childhood leukemia (LEA cohort) and
the norms, except for the leisure activities dimension.
These differences were not significant, except for the
general well-being score, which was significantly lower
in the children with IEMRD than in the LEA children
(p = 0.012), and for the relations with friends score,
which was lower in the children with IEMRD than in
the norms (p = 0.037).
The QoL scores of the adolescents over 11 years of age
are shown in Figure 2. Leisure was the dimension with
the most altered score, and the ‘social’ dimension scores
were the least altered. The scores of the adolescents with
Figure 1 QoL children (8–10 years): comparisons of dimensions scores between the IEMRD children and LEA cohort and French norms.
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dimension than the scores of the LEA cohort adolescents
and norms (p = 0.001 and p = 0.003, respectively). In
contrast, the adolescents with IEMRD scored better
than the norms for the relations with teachers (p = 0.029)
and better than the LEA adolescents for the relations
with medical staff (p < 0.001).
- QoL of children from parents’ reports The QoL scores
of children based on their parents’ views are reported
in Figure 3. Leisure and relations with friends were the
most affected dimensions, whereas the scores for relations
with teachers and medical staff were high. Compared
with the survivors of childhood leukemia, the children
with IEMRD assessed by their parents scored significantly
lower for the index (p = 0.049) and four ‘social’ and
‘physical’-like dimensions: physical well-being, leisure
activities, relations with friends, and vitality (p = 0.007,
p < 0.001, p < 0.001, and p = 0.024, respectively). However,
the parents scored higher for the relations with medical
staff (p = 0.002). Compared with the French norms, the
scores for leisure activities, relations with friends, and
body image were significantly lower for the children with
IEMRD (p = 0.001, p < 0.001, and p = 0.046, respectively).
QoL of parents
The QoL dimension scores were lower in the parents of
children with IEMRD than in the French norms. The
difference was only significant for the physical health
score (p < 0.05) (Figure 4).Factors modulating QoL of children with IEMRD and
their parents
The results for the factors modulating the QoL of the
children with IEMRD are provided in Additional file 1.
The children affected by urea cycle defects had lower
scores than children affected by the other two IEMRD
conditions, especially for the relationships with family
and body image dimensions. The vitality score was lower
for the children presenting with eating and neurologic
disorders. The score for psychological well-being was
higher for the children who reported receiving enteral
nutrition in the past. The index was not impacted by the
various sociodemographic and clinical parameters.
The results for the factors modulating the QoL of the
parents of children with IEMRD are shown in Additional
file 2. The WHOQOL scores did not differ according to
the sex of the child, nature of the IEMRD, feeding modality
at inclusion, or eating disorders. The parents of children
affected by neurologic disorders reported significantly
altered social relationships. The parents of children with
a current gastrostomy reported higher scores for two
dimensions: physical health and social relationships.
Relationships between QoL assessments of parents
and children
The results of the VSP-Ap (children’s QoL assessed by the
parents) and VSP-A/VSP-Ae (children’s QoL assessed by
the children themselves) only differed for the vitality score,
which was lower in the parents’ assessment (Additional
file 3).
Figure 2 QoL adolescents (11–18 years): comparisons of dimensions scores between the IEMRD adolescents and LEA cohort and
French norms.
Fabre et al. Health and Quality of Life Outcomes 2013, 11:158 Page 5 of 8
http://www.hqlo.com/content/11/1/158Discussion
An understanding of the impact of pediatric chronic ill-
nesses on QoL is important for the health care workers
who manage the relevant populations. We present one
of the first studies to specifically assess children with
IEMRD who are at risk of acute decompensation and
their parents. Consistent with previous studies, our
findings confirm that IEMRD impact the QoL of both
parents and children affected by IEMRD [20,33,34].
One publication explored the QoL of children with
maple syrup urine disease (MSUD), showing altered
QoL scores compared with controls and similar QoL
scores as children with cancer [33]. Among the studies
exploring the QoL of the parents, lower scores were
found than for the parents of children affected by other
chronic illnesses, such as sickle cell disease or Down
syndrome, or for controls [20,23,34].However, our results show that the ‘physical-like’ aspects
of QoL are more impacted than the ‘psychological-like’
aspects, both for parents and for children. Indeed, the
parents of these children reported lower scores on the
physical dimension of the WHOQOL than the controls,
and the children reported lower ‘physical’ scores than
leukemia survivors. One explanation is the well-known
phenomena of coping strategies and adjustment developed
by patients and/or families [35]. Relations with friends
and leisure activities were also defined by the children
as affected domains. We hypothesize that the dietary
regime constraints are partly responsible for these affects,
as shown in the comment that food preparation with
minute weighting and logistics are problematic. Even
if a parent stated always being prepared for potential
decompensation, he or she also asserted that it can be
hard to prepare for leisure and holidays. The limited diet
Figure 3 Children’ QoL reported by parents (VSP-Ap): comparisons of scores between the IEMRD sample and LEA cohort and norms.
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Alimentation plays a large cultural role; for example,
parents complained that certain aliment cannot be shared,
as these limitations are without exception. Moreover, in
certain cases, it was noted that there are few pleasures
in consuming food. These limits remain constant; indeed,Figure 4 Parents’ QoL: comparisons of WHOQOL scores
between the IEMRD parents and norms.in one study of approximately eight adults affected with
MSUD and their parents, the dietary constraint was
one of the major themes [18].
In contrast, the children reported better relationships
with medical staff than did the leukemia survivors. In
comparison with other chronic illnesses, such as cancer,
IEMRD has specific features. The disease is lifelong, as
opposed to cancer, for which the conventional treatment
does not cure the disease. There is the lifelong strain of
dietary management. Families and children face ongoing
metabolic decompensation and a risk of death with
decompensation and regularly visit hospitals and phy-
sicians throughout childhood. For all of the above reasons,
we hypothesize that the parents and their children have
faith in and rely on medical staff. Other authors did not
report this phenomenon [33], which can be explained
by the specifics of the health care system. The French
free health care system most likely allows parents to not
be worried by financial problems.
Interestingly, the presence of gastrostomy can have cer-
tain ‘protective effects’ on the self-reported QoL of parents,
notably in the physical health and social relationship
domains. A similar effect was previously shown [36], for
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bral palsy [37,38]. Many explanations should be discussed.
First, in case of enteral nutrition, gastrostomy removes
the necessity of an enteral feeding tube, which is more
apparent and less stable. Moreover, gastrostomy can be
easily used in cases of difficulties in eating. Second, it has
been previously reported that gastrostomy can decrease
parents’ stress [34,39]. Gastrostomy did not have an
influence on children’s QoL, as found for children with
cerebral palsy [40]. In our cohort, the patients with
urea cycle defects seemed to have a lower QoL, as
reported by their parents. The influence of the nature
of IEM was not explored in the previous studies [34].
This finding could be related to the more severe natural
course of the urea cycle defects, but we cannot exclude
the effect of the size of the study population.
Two limitations of our study must be mentioned:
i. Moderate associations were possibly missed because
of low statistical power due to the sample size,
which was arguably too small. The sample size did
not allow a multivariate approach that takes into
account the potential confounding factors. A larger
sample will allow the confirmation of these findings.
ii. Cross-sectional studies examine individuals with
heterogeneous disease durations. Longitudinal
studies provide more valid information and are
necessary to more accurately determine the weights
of potential predictive factors of QoL. Future studies
based on cohort studies should provide more robust
findings, particularly regarding the childhood/
adulthood transition, and should propose
appropriate treatment strategies.
Conclusion
The children and the parents of children affected with or-
ganic aciduria, urea cycle defects, or MSUD presented al-
tered ‘physical’ and ‘social’ QoL scores compared with the
norms and patients with leukemia and their families. Future
studies based on larger cohort studies should provide sup-
plementary findings to validate these preliminary results
and determine the different weights of potential predictive
factors of QoL, allowing the adaptation of appropriate care
strategies for children and their caregivers. Gastrostomy,
when required, can provide a degree of help to the parents.Additional files
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